Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.
Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.
复制标题
DOI:
10.1186/ar3097
复制
发表时间:
2010
影响因子:
4.9
通讯作者:
Varga J
中科院分区:
文献类型:
--
作者:
Castelino FV;Varga J
Interstitial lung disease (ILD) is a challenging clinical entity associated with multiple connective tissue diseases, and is a significant cause of morbidity and mortality. Effective therapies for connective tissue disease-associated interstitial lung disease (CTD-ILD) are still lacking. Multidisciplinary clinics dedicated to the early diagnosis and improved management of patients with CTD-ILD are now being established. There is rapid progress in understanding and identifying the effector cells, the proinflammatory and profibrotic mediators, and the pathways involved in the pathogenesis of CTD-ILD. Serum biomarkers may provide new insights as risk factors for pulmonary fibrosis and as measures of disease progression. Despite these recent advances, the management of patients with CTD-ILD remains suboptimal. Further studies are therefore urgently needed to better understand these conditions, and to develop effective therapeutic interventions.
登录
查看更多内容
DOI:
10.1164/rccm.200906-0964oc
发表时间:
2010-03-15
影响因子:
24.7
作者:
Daniels, Craig E.;Lasky, Joseph A.;Schroeder, Darrell R.
通讯作者:
Schroeder, Darrell R.
影响因子:
--
作者:
Ghosh, AK;Bhattacharyya, S;Varga, J
通讯作者:
Varga, J
影响因子:
6
作者:
Bhattacharyya, Swati;Chen, Shu-Jen;Varga, John
通讯作者:
Varga, John
DOI:
10.1164/rccm.2106012
发表时间:
2002-06-15
影响因子:
24.7
作者:
Bouros, D;Wells, AU;du Bois, RM
通讯作者:
du Bois, RM
DOI:
10.1164/rccm.200403-417oc
发表时间:
2005-03-15
影响因子:
24.7
作者:
Ito, I;Nagai, S;Mishima, M
通讯作者:
Mishima, M